A

Adherium

www.adherium.com link_icon

Company Research Report: Adherium Limited



Company Overview



Name:


  • Adherium Limited


Mission of the Company:


  • Adherium Limited is an international Respiratory eHealth company focused on patient adherence, remote monitoring, and data management solutions for patients, physicians, payers, and providers.


Founded:


  • The company was founded in 2001.


Founders:


  • No information is available.


Key People in the Company:


  • Dr Paul Mastoridis - Chief Executive Officer

  • Daniel Kaplon - Chief Financial Officer

  • Tara Creaven-Capasso - Vice President, Quality, Regulatory & Clinical Affairs

  • Nilesh Ghatpande - Vice President, Engineering & Technology

  • Cassandra Thomas - Vice President, People & Culture


Headquarters:


  • Level 2, 63 Albert Street, Auckland 1010, New Zealand


Number of Employees:


  • No information is available.


Revenue:


  • No information is available.


Known For:


  • Hailie® Smartinhaler® Technology: Adherium’s Hailie® Smartinhaler® technology and cloud-based data platform provide real-time feedback on patients' use of inhaled medication, enabling optimal management of difficult-to-treat and severe asthma and COPD, and reduce direct and indirect healthcare costs.


Values:


  • Integrity, Innovation, Accountability, High Performance, Customer-Focused.


Products



Hailie® Smartinhaler® Solution


  • High Level Description: A cloud-based platform that captures medication use data via Bluetooth® enabled sensors attached to inhalers.


  • Key Features:

  • Provides real-time feedback to patients through the Hailie® app.

  • Enables physicians to monitor adherence via the Hailie® portal.

  • Clinically proven to reduce the severity and frequency of exacerbations, hospital admissions, improving patient outcomes while reducing costs.

  • Supports the widest US inhaler market coverage and integrates with remote patient monitoring systems.


Recent Developments



New Products Launched:


  • Next Generation Sensors: Since 2022, Adherium has been developing new generation sensors that capture physiological parameters.

  • FDA-Cleared Smartinhaler for Airsupra® and Breztri® Inhalation Devices: Launched in 2024.


New Features Added:


  • No specific new features added to existing products are mentioned.


New Partnerships:


  • Valued Relationships Inc. (VRI): A strategic partnership secured in 2024.

  • Rimidi: Partnership to enhance respiratory clinical management solutions.

  • NuvoAir Medical and SENTA Partners: Partnerships to enhance patient outcomes.

  • Intermountain Health: Partnership for the distribution of Hailie® Smart Inhaler Sensors in the US.

  • Allergy Partners: Enrolled first patients and collaboration to target asthma management.


Other Developments:


  • FDA Clearances: Multiple FDA clearances including the Hailie® sensor for Ellipta®, Teva, and GSK inhalers.

  • Participation at American Thoracic Society (ATS) International Conference.

  • Featured in clinical studies to prevent asthma deaths, recognized by BBC News.


Conclusion


Adherium Limited is a pioneering company in the eHealth respiratory space, developing advanced smart inhaler technologies to improve patient adherence and remote monitoring. The company is strategically positioned to benefit from the growing adoption of telehealth and favorable remote patient monitoring reimbursement structures in the US. Their commitment to innovation, strategic partnerships, and enhancing clinical outcomes makes them a key player in the evolving healthcare industry.